Viewing Study NCT00488553



Ignite Creation Date: 2024-05-05 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00488553
Status: WITHDRAWN
Last Update Posted: 2012-02-24
First Post: 2007-06-19

Brief Title: Molecular Epidemiology of Lymphoma Patients
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Study Overview

Official Title: Molecular Epidemiology of Lymphoma Patients
Status: WITHDRAWN
Status Verified Date: 2012-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: No participants recruited study discontinued
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Primary Objectives

1 To enroll and obtain through questionnaires risk factor information on all study participants to develop detailed demographic epidemiologic and behavioral profiles
2 To assess the influence of relevant epidemiologic covariates such as age gender smoking and family history of cancer on the panel of susceptibility biomarkers
3 To evaluate the role of genomic instability in development of lymphomas
Detailed Description: This study will include individuals diagnosed with lymphoma and individuals with no history of cancer Half of the participants in this study will have lymphoma and half will have no history of cancer Information from both groups will be compared to help researchers try to learn which factors may lead to the development of lymphoma

If you agree to take part in this study you will be asked to complete a questionnaire at M D Anderson In this questionnaire you will be asked about your demographics such as your age sex etc certain environmental exposures such as pollution your medical history family history diet and your past and present smoking and alcohol use habits This questionnaire should take about 50 minutes to complete

You will also have about 2 ½ tablespoons of blood drawn for special tests These tests will look for any biologic factors such as changes in your DNA that may be linked to lymphoma You will not be informed of the results of any of the testing done with your blood samples

Your participation will be over in this study once your blood has been drawn

This is an investigational study Up to 800 participants will take part in this study All will be enrolled at M D Anderson

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None